| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Fendx Technologies Inc (2): Fendx Technologies to settle 34,540 shares for debt | 2 | Stockwatch | ||
| Sa | FendX Technologies Inc.: FendX Provides Corporate Update | 347 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 21, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| Fr | Zentek Ltd: Zentek receives CRA reassessment for 2019 | 1 | Stockwatch | ||
| Fr | Zentek Ltd.: Zentek Receives CRA Notice of Reassessment for 2019 | 232 | ACCESS Newswire | GUELPH, ONTARIO / ACCESS Newswire / November 21, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that, further to its press release dated March 21, 2025 regarding the... ► Artikel lesen | |
| Fr | Zentek Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| Fr | ONTO INNOVATION INC. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Fr | ANLEIHEN-Woche KW47 - 2025: Schalke 04, reconcept, PANDION, SUNfarming, Werder Bremen, AREAM, paragon, Mutares, EPH, BOOSTER Precision, LR Health, JDC, Pferdewetten, PORR, Formycon, … | 1.585 | Anleihen Finder | Volltreffer am Anleihemarkt In der Kalenderwoche 47 sorgt der FC Schalke 04 für die Schlagzeile der Woche: Die Königsblauen schließen die Platzierung ihrer neuen 6,50%-Unternehmensanleihe 2025/30 (ISIN:... ► Artikel lesen | |
| Fr | NEXSEN LIMITED: Results of AGM | 1 | ASX | ||
| Fr | REGION GROUP: Change of Director's Interest Notice | - | ASX | ||
| Fr | REGION GROUP: Change of Director's Interest Notice | - | ASX | ||
| Do | NEXSEN LIMITED: Chairman's Address to AGM | - | ASX | ||
| Do | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| Do | Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy | 525 | EQS Group (EN) | Original-Research: Formycon AG - from First Berlin Equity Research GmbH
20.11.2025 / 17:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is... ► Artikel lesen | |
| Do | Formycon AG: Biosimilar Epruvy ab sofort in Deutschland verfügbar | 658 | Anleihen Finder | Mitteilung der Formycon AG: Ranibizumab-Biosimilar Epruvy ab sofort in Deutschland verfügbar - Sandoz vermarktet Epruvy1 in Deutschland als Fertigspritze (PFS) und Durchstechflasche im Rahmen einer... ► Artikel lesen | |
| Do | Formycon: Ranibizumab-Biosimilar Epruvy startet in Deutschland | 393 | 4investors | Die Formycon AG meldet gemeinsam mit der Bioeq AG den Start der Vermarktung des Ranibizumab-Biosimilars Epruvy in Deutschland. Das Medikament wird von Sandoz im Rahmen einer Lizenzvereinbarung mit Bioeq... ► Artikel lesen | |
| Do | SMOLTEK NANOTECH HOLDING AB: Smoltek launches podcast about materials technology and investments | 1 | Cision News | ||
| Do | EQS-News: Formycon AG: Ranibizumab-Biosimilar Epruvy ab sofort in Deutschland verfügbar | 494 | EQS Group (DE) | EQS-News: Formycon AG
/ Schlagwort(e): Produkteinführung
Ranibizumab-Biosimilar Epruvy ab sofort in Deutschland verfügbar
20.11.2025 / 06:30 CET/CEST
Für den Inhalt... ► Artikel lesen | |
| Mi | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| Mi | FORMYCON AG zündet heute den Turbo - ich bin geflasht! | 17 | Maximilian Berger | ||
| Mi | BIOFORCE NANOSCIENCES HOLDINGS, INC. - 10-Q, Quarterly Report | - | SEC Filings |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| ONTO INNOVATION | - | 6 | -0,90 % | ONTO INNOVATION INC. - S-8, Securities to be offered to employees in employee benefit plans | |||
| NANOFOCUS | - | 3 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | ||
| FORMYCON | - | 3 | -0,64 % | EQS-News: Formycon AG: Meilenstein bei FYB208 erreicht: Biosimilar-Kandidat für Dupixent (Dupilumab) als weiterer Wachstumstreiber im Formycon-Portfolio | EQS-News: Formycon AG
/ Schlagwort(e): Sonstiges
Meilenstein bei FYB208 erreicht: Biosimilar-Kandidat für Dupixent® (Dupilumab) als weiterer Wachstumstreiber im Formycon-Portfolio... ► Artikel lesen | ||
| ANTEOTECH | - | 3 | - | Anteotech Hits Key Performance Benchmarks in Testing of Ultranode X High-Silicon Battery | |||
| ZENTEK | - | 3 | -0,78 % | Zentek Ltd.: Zentek Receives CRA Notice of Reassessment for 2019 | GUELPH, ONTARIO / ACCESS Newswire / November 21, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that, further to its press release dated March 21, 2025 regarding the... ► Artikel lesen | ||
| SOLESENCE | - | 2 | +4,78 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | ||
| VEECO INSTRUMENTS | - | 2 | -3,36 % | Veeco Instruments Inc.: Veeco Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Highlights: Revenue of $165.9 million, compared with $184.8 million in the same period last yearGAAP net income of $10.6 million, or $0.17 per diluted share, compared with $22.0... ► Artikel lesen | ||
| RIBER | - | 2 | -1,15 % | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m... ► Artikel lesen | ||
| FENDX TECHNOLOGIES | - | 2 | +16,11 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - November 21, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | ||
| GAUZY | - | 2 | -8,28 % | Gauzy Ltd. Announces Second Quarter 2025 Results | Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| FORMYCON AG | 23,150 | 51 | +120 % | 4 | - | - |